In a small study, doctors at Johns Hopkins have successfully transplanted 10 hepatitis C-infected kidneys into patients without hepatitis C and prevented the patients from becoming infected by hepatitis C. The success of ...
Mar 5, 2018
0
41
A group of Brazilian scientists has achieved promising results using isolated compounds from the venom of the South American rattlesnake to combat hepatitis C. The investigation was based on records in scientific literature ...
Feb 9, 2018
0
800
The World Health Organisation set a goal to eliminate hepatitis C by 2030. The NHS recently announced that it will go one better than that: it will eliminate the disease in England by 2025. In theory, the goal is achievable, ...
Feb 5, 2018
0
1
Over the last two decades, deaths caused by liver cancer have increased by 80%, making it one of the fastest-growing causes of cancer deaths worldwide.
Feb 1, 2018
0
14
(HealthDay)—Once-daily treatment with glecaprevir-pibrentasvir appears safe and effective for the treatment of hepatitis C virus (HCV) genotype 1 or 3, according to a study published in the Jan. 25 issue of the New England ...
Jan 31, 2018
0
2
Reducing chronic hepatitis B infections by screening at-risk adults, increasing hepatitis B vaccination rates, and linking infected persons to care is a public health priority, the American College of Physicians (ACP) and ...
Nov 20, 2017
0
0
As public health officials worry that the increase of opioid use among young adults has helped to spread the hepatitis C virus to a new generation, a study in Rhode Island finds that while screening is common, the follow-up ...
Oct 25, 2017
0
0
Hepatitis C virus is a curable infectious disease, but treatment remains unavailable in resource-limited settings like the Democratic Republic of the Congo (DRC). The DRC Ministry of Health asked the University of North Carolina ...
Oct 18, 2017
0
0
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...
Oct 13, 2017
0
45
(HealthDay)—For patients with stage 4 or 5 chronic kidney disease and hepatitis C virus (HCV) infection, 12 weeks of treatment with glecaprevir and pibrentasvir results in a high rate of sustained virologic response, according ...
Oct 12, 2017
0
0
